What it's for (Indications)
- Fluorometholone ophthalmic suspension is indicated for the treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.
- This includes, but is not limited to, allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis (with extreme caution), iritis, cyclitis, selected infective conjunctivitides (where the inherent risk of steroid use is accepted to obtain a diminution in edema and inflammation), and various other anterior uveitis conditions.
- It is also utilized for the management of post-operative inflammation following ocular surgery.
- Its moderate anti-inflammatory potency is often preferred when a less potent steroid is desired to minimize the risk of intraocular pressure elevation, while still providing effective inflammation control in sensitive eye tissues.
- This targeted application aims to reduce inflammation and associated symptoms such as redness, swelling, and discomfort, thereby aiding in the recovery and preservation of ocular health and function.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For the treatment of ophthalmic inflammation, fluorometholone ophthalmic suspension should be administered by instilling one drop into the conjunctival sac two to four times daily. During the initial 24 to 48 hours of treatment, the dosage may be safely increased to one drop every four hours if deemed clinically necessary to achieve rapid control of inflammation. It is imperative that care should be taken not to discontinue therapy prematurely, as this may lead to a recurrence or rebound of the inflammatory condition. The duration of treatment should be determined by the treating physician based on the patient's response and ongoing clinical findings, often requiring gradual tapering. For the ophthalmic ointment form, a small amount (approximately a half-inch ribbon) is typically applied to the conjunctival sac one to three times daily, depending on the severity of the condition and physician's instructions. Adherence to the prescribed dosage regimen is crucial for optimal therapeutic outcomes and minimizing adverse effects. |
Safety & Warnings
Common Side Effects
- The use of fluorometholone ophthalmic preparations can lead to several potential side effects, predominantly affecting the eye.
- The most significant and frequently monitored ocular adverse reactions include increased intraocular pressure (IOP), which may eventually lead to glaucoma with associated optic nerve damage, visual field defects, and posterior subcapsular cataract formation, particularly with prolonged use.
- Other common ophthalmic effects may include transient stinging or burning sensation upon instillation, foreign body sensation, blurred vision, photophobia, conjunctival hyperemia, and ptosis.
- Less common but serious effects include the development of secondary ocular infections (bacterial, fungal, viral) due to local immunosuppression, and perforation of the globe in areas where the cornea or sclera are thinned by disease processes.
- Systemic absorption leading to systemic corticosteroid effects (e.
- g.
- , adrenal suppression) is rare with ophthalmic use but can occur, especially with prolonged, high-frequency dosing or in susceptible pediatric patients.
- All patients should report any new or worsening symptoms to their ophthalmologist promptly.
Serious Warnings
- Black Box Warning: **Serious Warnings Regarding Ophthalmic Corticosteroid Use (No Formal FDA Black Box Warning):** While fluorometholone ophthalmic preparations do not carry an official FDA Black Box Warning, healthcare professionals and patients must be fully aware of several serious risks associated with their use. Prolonged administration of ophthalmic corticosteroids, including fluorometholone, can significantly elevate intraocular pressure (IOP), potentially leading to irreversible optic nerve damage, visual field defects, and the development of glaucoma. Regular and diligent monitoring of IOP is therefore paramount for any patient receiving extended therapy, especially those with pre-existing glaucoma, diabetes, or a family history of ocular hypertension. Additionally, posterior subcapsular cataracts have been reported with long-term corticosteroid use, impacting visual acuity and potentially necessitating surgical intervention to restore vision. Corticosteroids are known to suppress the host immune response, rendering the eye more susceptible to secondary ocular infections, particularly those caused by fungi, viruses (e.g., active herpes simplex keratitis), and bacteria. The use of fluorometholone in the presence of an untreated infection can mask the progression of the infection, leading to delayed diagnosis and further compromise of ocular health. In conditions causing thinning of the cornea or sclera, the application of topical steroids may lead to perforation of the globe. Patients should be strictly advised against self-medication and to adhere to prescribed follow-up schedules to mitigate these serious risks and ensure safe and effective treatment, reporting any changes in vision or discomfort immediately. Misuse or prolonged use without supervision can lead to irreversible visual impairment.
- Patients receiving fluorometholone ophthalmic preparations should be closely monitored due to several significant risks.
- Prolonged use of ophthalmic corticosteroids, even those with a relatively lower potential for IOP elevation like fluorometholone, may result in ocular hypertension and/or glaucoma, with damage to the optic nerve, defects in visual acuity and fields of vision, and posterior subcapsular cataract formation.
- Regular intraocular pressure monitoring is therefore essential, especially in patients with a history of glaucoma, diabetes, or those receiving prolonged therapy extending beyond 10 days.
- Corticosteroids can also mask, enhance, or exacerbate existing ocular infections or predispose the eye to secondary ocular infections (bacterial, fungal, viral, parasitic).
- Particular caution is advised in patients with active herpes simplex keratitis, as corticosteroids may worsen the condition and potentially lead to severe corneal damage or perforation.
- In conditions causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical steroids.
- Healing of corneal abrasions or wounds may also be delayed.
- Patients should be advised not to wear contact lenses during treatment for ocular inflammation, and sterile technique should be maintained during application to prevent contamination.
- Withdrawal should be gradual if therapy is prolonged.
How it Works (Mechanism of Action)
Fluorometholone is a potent synthetic corticosteroid designed for ophthalmic use, exerting its therapeutic effects primarily through its robust anti-inflammatory and immunosuppressive properties. Upon topical ocular administration, it penetrates the cell membranes of ocular tissues and forms a complex with specific cytoplasmic receptors. This steroid-receptor complex then translocates into the cell nucleus, binds to specific DNA sequences known as glucocorticoid response elements, and modulates the transcription of various genes. Specifically, fluorometholone inhibits the inflammatory response to a wide array of inciting agents by inducing the synthesis of phospholipase A2 inhibitory proteins, collectively known as lipocortins. These lipocortins play a critical role in regulating the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes, by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is liberated from membrane phospholipids by the action of phospholipase A2. By effectively reducing the production and release of these inflammatory mediators, fluorometholone diminishes the cardinal signs of inflammation including edema, fibrin deposition, capillary dilation, leukocyte migration, collagen deposition, and subsequent scar formation, thereby restoring tissue integrity and reducing ocular discomfort.
Commercial Brands (Alternatives)
No other brands found for this formula.